Murali K. Prahalad

Former Director at Epic Sciences, Inc.

Murali K. Prahalad

Murali K. Prahalad

Former Director at Epic Sciences, Inc.

Biography

Murali K. Prahalad is on the board of Epic Sciences, Inc. (former President & Chief Executive Officer). In his past career Dr. Prahalad was Vice President-Corporate Strategy at Life Technologies Corp. and Vice President-Business Development at Sequenom, Inc. Murali K. Prahalad received a graduate degree and a doctorate from Harvard University and an undergraduate degree from the University of Michigan.

Overview
Career Highlights

Epic Sciences, Inc.

RelSci Relationships

394

Number of Boards

1

Relationships
RelSci Relationships are individuals Murali K. Prahalad likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Corza Health, Inc.

Relationship likelihood: Strong

Co-Founder at Gritstone Oncology, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Epic Sciences, Inc.

Relationship likelihood: Strong

Chief Commercial Officer at Epic Sciences, Inc.

Relationship likelihood: Strong

General Counsel & Executive Vice President of Corporate Development at Epic Sciences, Inc.

Relationship likelihood: Strong

Chief Technology Officer at Epic Sciences, Inc.

Relationship likelihood: Strong

Executive Director, Wwbd & Senior Partner at Pfizer Venture Investments

Relationship likelihood: Strong

Partner at Domain Associates LLC

Relationship likelihood: Strong

Managing Partner at Blue Ox Healthcare Partners LLC

Relationship likelihood: Strong

Principal at Deerfield Management Company LP

Relationship likelihood: Strong

Paths to Murali K. Prahalad
Potential Connections via
Relationship Science
You
Murali K. Prahalad
Former Director at Epic Sciences, Inc.
Education
BS in Cellular & Molecular Biology & Economics with Honors

The University of Michigan (UM, U-M, UMich, or U of M), frequently referred to as simply Michigan, is a public research university located in Ann Arbor, Michigan, United States. It is the state's oldest university and the flagship campus of the University of Michigan. It is one of the original eight Public Ivy universities and is one of the founding members of the Association of American Universities. It has been ranked among the top five research universities in the US, and among the top 20 universities in the world. U-M also has satellite campuses in Flint and Dearborn.

PhD in Biochemistry & Molecular Pharmacology

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

Career History
Director
2013 - 2019

Epic Sciences is a company that was founded to develop medical diagnostics characterizing circulating tumor cells; its initial product offering was a non-medical service offering analysis services to companies developing drugs. Epic was founded in 2008, and technology was licensed from Scripps Research Institute, based on inventions made by Peter Kuhn's lab at Scripps. The company's approach involves getting a blood sample, removing red blood cells, putting the remaining cells on a microscope slide, staining the cells with antibodies for a few cancer markers, imaging the slide, then using proprietary image analysis software that counts the stained cells and analyzes the cells based on morphophology and other factors; as of 2014 it took the software around two and a half hours to analyze a single slide; around 12 slides are generated from a standard 7.5 mL blood sample. As of 2014 it was offering its analysis services to drug companies as a way to measure outcomes in clinical trials. David Nelson was the first President and CEO and in 2012 Epic raised $13M in 2012 from Domain Associates, Roche Venture Fund and Pfizer Venture Investments. By 2014 Murali Prahalad was president and CEO and in July of that year the company raised an additional $30M. In April 2017, Epic raised another $40 million and as of that date had raise a total of $85.5 million.

Vice President, Corporate Strategy
2005 - Prior

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics. The company manufactures both molecular diagnostic and research use only products. Life Technologies' industry-leading brands are found in nearly every life sciences lab in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent names, as well as, the broadest range of reagents with its Invitrogen, GIBCO, Ambion, Molecular Probes products. Life Technologies had sales of $3.7 billion in 2011, employs approximately 10,400 people, has a presence in approximately 160 countries, and possesses one of the largest intellectual property estates in the life sciences industry, with approximately 4,000 patents and exclusive licenses. For more information on how we are making a difference, please visit our website: www.lifetechnologies.com

Vice President, Business Development
Prior

Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in San Diego, CA.

Other Affiliations

Murali K. Prahalad is affiliated with Epic Sciences, Inc., Life Technologies Corp., Sequenom Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Murali K. Prahalad. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Murali K. Prahalad's profile does not indicate a business or promotional relationship of any kind between RelSci and Murali K. Prahalad.